Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises CGI on its offer for Acando
Mandate

Vinge advises CGI on its offer for Acando

March 11, 2019 Capital Markets and Public M&A

CGI Inc. has announced a recommended cash offer to the shareholders of Acando AB (publ) to tender all their shares in Acando to CGI.

The total offer value for all outstanding shares in Acando amounts to approximately SEK 4,320 million.

Vinge advises CGI. The Vinge team includes Erik Sjöman, Malte Hedlund, Anna-Karin Alin, Anna Edström, Lena Lundahl, Marcus Glader, Trine Osen Bergqvist, Emma Johansson, Anna Grigorian and Victor Ericsson.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025